Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy

Journal of Neurochemistry

Volumn 73, Issue 2, 1999, Pages 881-884

  Albers, David S ^a,b   Augood, Sarah J ^a   Martin, Deborah M ^a   Standaert, David G ^a   Vonsattel, Jean Paul G ^a   Beal, M Flint ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Free radicals; Lipid peroxidation Malondialdehyde; Neurodegenerative disorders; Progressive supranuclear palsy; Subthalamic nucleus

Indexed keywords

FREE RADICAL; MALONALDEHYDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBTHALAMIC NUCLEUS;

AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NERVE DEGENERATION; OXIDATIVE STRESS; SUPRANUCLEAR PALSY, PROGRESSIVE; THALAMIC NUCLEI;

EID: 0032814138     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730881.x     Document Type: Article

References (27)

1. Albin R., Aldridge J., Young A., and Gilman S. (1989) Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Res. 491, 185-188.
2. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., and Hutton M. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711-715.
3. 3H]kainate. Brain Res. 26, 209-218.
4. Beal M. (1997) Oxidative damage in neurodegenerative diseases. Neuroscientist 3, 21-27.
5. Benazzouz A., Gross C., Feger J., Boraud T., and Bioulac B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5, 382-389.
6. Bergman H., Wichmann T., and DeLong M. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438.
7. Beurrier C., Bezard E., Bioulac B., and Gross C. (1997) Subthalamic stimulation elicits hemiballismus in normal monkey. Neuroreport 8, 1625-1629.
8. Blin J., Baron J., Dubois B., Pillon B., Cambon H., Cambier J., and Agid Y. (1990) Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic patter and clinico-metabolic correlations. Arch. Neurol. 47, 747-752.
9. Chavany J., Bogaert Lv., and Godlewski S. (1951) Sur un syndrome de rigidité à predominance axiale avec perturbation des automatismes oculo-palpebraux d'origine encephalitique. Presse Med. 50, 958-962.
10. Conrad C., Andreadis A., Trojanowski J. Q., Dickson D. W., Kang D., Chen X., Wiederholt W., Hansen L., Masliah E., Thal L. J., Katzman R., Xia Y., and Saitoh T. (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41, 277-281.
11. Dexter D., Wells F., Agid F., Agid Y., Lees A., and Jenner P. (1987) Increased nigral iron content in post-mortem parkinsonian brain. Lancet 2, 1219-1220.
12. Dexter D., Carter C., Wells F., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
13. Dexter D., Sian J., Rose S., Hindmarsh J., Mann V., Cooper J., Wells F., Daniels S., Lees A., Schapira A., Jenner P., and Marsden C. (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35, 38-44.
14. Di Monte D., Harati Y., Jankovic J., Sandy M. S., Jewell S. A., and Langston J. W. (1994) Muscle mitochondrial ATP production in progressive supranuclear palsy. J. Neurochem. 62, 1631-1634.
15. Eve D. J., Nisbet A. P., Kingsbury A. E., Hewson E. L., Daniel S. E., Lees A. J., Marsden C. D., and Foster O. J. (1998) Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Mol. Brain Res. 10, 62-71.
16. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H. Jr., and Beal M. F. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074.
17. Halliwell B. and Chirico S. (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nuir. 57 (Suppl.), 715S-724S.
18. Hauw J. J., Daniel S. E., Dickson D., Horoupian D. S., Jellinger K., Lantos P. L., McKee A., Tabaton M., and Litvan I. (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015-2019.
19. Joel D. and Weiner I. (1997) The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Res. Rev. 23, 62-78.
20. Klivenyl P., Ferrante R., Matthews R., Bogdanov M., Klein A., Andreassen O., Muller G., Werner M., Kaddurah-Daouk R., and Beal M. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5, 347-350.
21. Koroshetz W. J., Jenkins B. G., Rosen B. R., and Beal M. F. (1997) Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann. Neurol. 41, 160-165.
22. Litvan I., Hauw J., Bartko J., Lantos P. L., Daniel S. E., Horoupian D. S., McKee A., Dickson D., Bancher C., Tabaton M., Jellinger K., and Anderson D. W. (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J. Neuropathol. Exp. Neurol. 55, 97-105.
23. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D., Sambrook M. A., and Crossman A. R. (1989a) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32, 213-226.
24. Mitchell I. J., Jackson A., Sambrook M. A., and Crossman A. R. (1989b) The role of the subthalamic nucleus in experimental chorea. Evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies. Brain 112, 1533-1548.
25. Rinvik E. and Ottersen O. (1993) Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopic, immunogold analysis in the cat. J. Chem. Neuroanat. 6, 19-30.
26. Sanchez-Ramos J., Overik E., and Ames B. (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 3, 197-204.
27. Steele J., Richardson J., and Olszewski J. (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10, 333-359.